The ATN Framework—Moving Preclinical Alzheimer Disease to Clinical Relevance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The ATN Framework—Moving Preclinical Alzheimer Disease to Clinical Relevance

Published:2022-10-01 Issue:10 Volume:79 Page:968
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

van der Flier Wiesje M.¹²³,Scheltens Philip¹²⁴

Affiliation:

1. Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands

2. Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands

3. Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands

4. EQT Life Sciences, Amsterdam, the Netherlands

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2796885/jamaneurology_van_der_flier_2022_ed_220014_1664471655.58568.pdf

Reference16 articles.

1. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease.;Jack;Alzheimers Dement,2018

2. The Global Deterioration Scale for assessment of primary degenerative dementia.;Reisberg;Am J Psychiatry,1982

3. Clinical diagnosis of Alzheimer’s disease: recommendations of the International Working Group.;Dubois;Lancet Neurol,2021

4. Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review.;van der Schaar;Alzheimers Res Ther,2022

5. Association of elevated amyloid and tau positron emission tomography signal with near-term development of alzheimer disease symptoms in older adults without cognitive impairment.;Strikwerda-Brown;JAMA Neurol

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rethinking the residual approach: Leveraging machine learning to operationalize cognitive resilience in Alzheimer’s disease;2024-08-20

2. Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time;Alzheimer's & Dementia;2024-08

3. Synapse protein signatures in cerebrospinal fluid and plasma predict cognitive maintenance versus decline in Alzheimer’s disease;2024-07-23

4. Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease;Acta Biomaterialia;2024-07

5. Unraveling the Tau Puzzle: A Brief Discussion on Biomarkers in Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3